Domenico D'Ugo

Plain English
This study looked at rectal cancer surgery outcomes for patients over 70 years old, who make up 44% of all rectal cancer cases in Italy. It found that 90-day postoperative mortality rates are similar between older patients (1.05%) and younger patients (0.41%), indicating that age alone should not prevent elderly patients from having surgery. However, older patients experienced more general complications and stayed in the hospital longer, but their overall cancer treatment results were still comparable to younger patients. Who this helps: This helps elderly patients with rectal cancer and their doctors make informed treatment decisions.

Plain English
This study looked at how well a combination treatment of surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) works for patients with advanced gastric cancer that has spread within the abdominal cavity. Researchers analyzed data from 193 patients and found that those who achieved a good surgical outcome had much better survival rates: 87% were alive after one year, compared to 57% for those who didn’t achieve that outcome. This matters because it highlights the importance of both surgery and HIPEC for better long-term health in these patients. Who this helps: Patients with advanced gastric cancer and their doctors.

Plain English
This study looked at how a tool called the Prognostic Nutritional Index (PNI) can predict outcomes for European patients with advanced gastric cancer who are receiving various treatments. Researchers analyzed data from over 700 patients and found that those with a low PNI (30% of the patients) were less likely to achieve a good surgical outcome and had a higher risk of dying within 90 days after surgery. Specifically, patients with low PNI had about half the odds of achieving a good outcome and were five times more likely to die in that period compared to those with higher PNI scores. Who this helps: This research helps doctors better assess risks in gastric cancer patients and improve treatment plans based on nutritional health.

Plain English
This study compared the outcomes of two surgical methods for gastric cancer: open gastrectomy (OG) and minimally invasive gastrectomy (MIG) in patients across 24 European hospitals. Researchers found that MIG led to fewer complications (23% compared to 31.6% for OG), shorter hospital stays, and lower mortality rates within 30 days (1.6% vs. 3.3%) and 90 days (1.9% vs. 4.7%). These findings are important because they suggest that for patients with smaller or earlier-stage tumors, minimally invasive surgery can lead to better recovery experiences. Who this helps: This helps patients with gastric cancer who may have options for safer, less invasive surgery.

Plain English
This study looked at the use of staging laparoscopy (SL), a procedure used to better assess the extent of locally advanced gastric cancer, in 1,726 patients across 24 European centers. It found that only 33% of patients underwent SL, and those who didn’t tended to be older, have more health issues, and experience higher rates of complications (30.9% vs. 24.4%) and 90-day mortality (4.7% vs. 2.3%). This matters because patients who had SL were more likely to receive important chemotherapy treatments, leading to better overall management of their cancer. Who this helps: This information benefits doctors and healthcare providers by highlighting the importance of SL for improving treatment outcomes in gastric cancer patients.

Plain English
This study looked at rectal cancer patients to improve how we predict the chances of cancer returning after treatment. Researchers analyzed data from 2,450 patients and developed two models to make these predictions. The advanced model (Model B) was much better than the traditional model, with an accuracy score of 0.95 compared to 0.78, which means it can give more reliable and personalized predictions. Who this helps: This benefits doctors and patients by enabling more informed decisions regarding follow-up care.

Plain English
This study looked at the long-term effects of a type of surgery called Roux-en-Y total gastrectomy (RYTG) on 80 patients who had stomach cancer or a specific genetic mutation. The researchers found that on average, patients lost about 19.4% of their body weight after surgery, and 27.5% experienced dumping syndrome, which can cause uncomfortable digestive problems. These issues can significantly lower patients' quality of life, indicating a need for better surgical options to avoid these complications. Who this helps: This research benefits patients who undergo total gastrectomy and their healthcare providers.

Plain English
This study explored how advanced imaging techniques, known as radiomics, can help predict how well patients with stomach cancer respond to different chemotherapy treatments before surgery. Researchers examined the CT scans of 77 patients and developed models that showed high accuracy: one model predicted major responses to treatment with 83% sensitivity and a notable negative predictive value of 96%. This is important because it can guide doctors in choosing the most effective treatment plans for patients, potentially improving outcomes. Who this helps: This helps patients with gastric and gastroesophageal cancer and their doctors in making more informed treatment decisions.

Plain English
This study focused on improving a complex type of minimally invasive surgery called the Ivor-Lewis oesophagectomy, which is used to treat esophageal cancer. Researchers introduced a new method using a circular stapling technique that made the surgery easier and safer. The patient who underwent this procedure recovered well and was free of disease nine months later. Who this helps: This benefits patients undergoing esophageal cancer surgery.

Plain English
This research examined two prediction models, PERI-Gastric 1 and PERI-Gastric 2, to see how well they could forecast the risk of cancer returning in the peritoneum (the lining of the abdominal cavity) after patients underwent surgery for stomach cancer. The study involved 8,564 patients and found that both models were reasonably accurate, with scores indicating a fair ability to predict recurrence risks between 24% and 47%. This matters because it helps doctors better tailor follow-up treatments and care for patients, potentially improving outcomes. Who this helps: Patients with gastric cancer and their healthcare providers.

Plain English
This study created new guidelines for doctors on how to define, diagnose, and treat a specific type of cancer called oligometastatic esophagogastric cancer, which can occur when cancer spreads to a limited number of locations. Researchers reviewed data from multiple studies and found that patients with one organ affected by three or fewer metastases could benefit from targeted treatments. These guidelines aim to improve care for patients and ensure consistent treatment approaches across Europe. Who this helps: These guidelines help patients with oligometastatic esophagogastric cancer and their doctors.

Plain English
This study focused on a patient with a rare type of stomach cancer called cardia adenocarcinoma, which had spread to his liver. After starting a specific chemotherapy treatment, this 49-year-old man showed an outstanding response, with no signs of cancer for over four years after his initial diagnosis. This finding is important because it highlights the potential for some patients to achieve long-lasting benefits from chemotherapy, even in advanced cancer cases. Who this helps: This information is beneficial for patients with metastatic cardia adenocarcinoma and their doctors, as it provides hope for exceptional recovery outcomes.

Plain English
This paper looks at how to treat severe stomach and esophagus cancers, which are rapidly changing as new methods and technologies emerge. The authors highlight various approaches, such as using robotic surgery, focusing on specific tumor types, and incorporating new treatments like immune therapies. These updates are crucial as they aim to improve patient care and outcomes for those affected by these cancers. Who this helps: This benefits patients with gastro-esophageal cancers, as well as the doctors who treat them.

Plain English
This study looked at Clostridium difficile infection (CDI) in patients who had surgery to reverse a stoma, such as a colostomy or ileostomy. They found that about 2.1% of these patients developed CDI after the surgery. Notably, patients who received adjuvant therapy (additional cancer treatment after surgery) had a higher risk of getting CDI. Who this helps: This information is important for doctors and patients, especially those with cancer, to better understand the risks associated with stoma reversal surgery.

Plain English
This study examined different surgical methods used in minimally invasive stomach surgeries for cancer to see how they affect recovery complications. Researchers looked at data from over 9,000 surgeries and found that patients undergoing total gastrectomy (miTG) had higher rates of complications like leaks (5.2% compared to 1.1% for distal gastrectomy, miDG), and overall complications were also higher (28.7% for miTG vs. 16.3% for miDG). The findings suggest that minimally invasive distal gastrectomy is safer than total gastrectomy, and specific techniques, like linear stapling, result in fewer problems. Who this helps: This helps patients undergoing stomach cancer surgery by providing insights into safer surgical options.

Plain English
This study focused on creating a clear definition for a "textbook outcome" (TO) in colorectal surgery for cancer patients in Italy. The experts agreed that the ideal outcome includes 90-day survival rates, clear cancer margins after surgery, and specific guidelines to minimize complications and ensure comprehensive care. This matters because it standardizes the quality of surgical care for colorectal cancer patients, aiming to improve their overall treatment experience. Who this helps: This helps patients undergoing colorectal cancer surgery by ensuring consistent and high-quality care.

Plain English
This study looked at how to treat patients with tears or leaks in their esophagus—either from injuries or surgery—over a 15-year period, involving 60 patients. They found that 56 of these patients were successfully treated using minimally invasive methods without needing to remove the esophagus, with an average recovery time of about 55 days. Only one patient died, and serious complications were rare, showing that working together across different medical specialties can effectively manage these serious conditions and keep the esophagus intact. Who this helps: Patients facing esophageal injuries or leaks and their doctors.

Plain English
This study examined the risk of lymph node metastasis (cancer spread) in patients with a specific type of early gastric cancer called pT1b, comparing data from Eastern and Western countries. They found that about 22.1% of patients in Eastern countries and 27.3% in Western countries had lymph node metastasis. For patients meeting certain criteria, the likelihood of metastasis dropped to 8.9%, and to only 3.4% for those with specific tumor characteristics. This matters because it can help doctors decide if a less invasive treatment option is safe for patients with early gastric cancer. Who this helps: Patients with early gastric cancer who are considering treatment options.

Plain English
This study looked at patients who experienced complications after stomach cancer surgery in Italy. Researchers collected data from 386 patients over four years, finding that 12.4% of them died after surgery, with a particularly high death rate of 25.4% for those with a specific type of complication called anastomotic leak. Understanding these complications and their impact is important for improving post-surgery care and reducing death rates. Who this helps: This helps patients undergoing gastric cancer surgery and their doctors in managing post-operative care.

Plain English
This study compared two surgical methods for treating cancer in the splenic flexure of the colon: minimally invasive surgery (MIS) and open surgery. It found that both methods had similar patient outcomes; for example, both had high rates of successful short-term recovery at around 93%. This is important because it shows that minimally invasive surgery is as effective as traditional open surgery, offering patients a less invasive option with potentially fewer complications. Who this helps: Patients with splenic flexure cancer benefit from having a safer surgical option.

Plain English
Researchers are trying to create a clear definition and treatment plan for patients with oligometastatic esophagogastric cancer, which is when cancer has spread to a few locations outside the original site. The OligoMetastatic Esophagogastric Cancer (OMEC) project involves five studies aimed at gathering expert opinions, reviewing existing data, and ultimately developing a comprehensive guideline for treatment. This matters because having a standardized approach could help improve the care and outcomes for these patients. Who this helps: This helps patients with oligometastatic esophagogastric cancer and their doctors.

Plain English
This study looked at two blood tests, procalcitonin (PCT) and C-reactive protein (CRP), to see which one better predicts complications after stomach surgery, specifically anastomotic leakage (AL) and major infections. Researchers found that the rate of AL was 4.6% and major infections occurred in 19.9% of patients. While PCT showed some links to complications, CRP was found to be the better marker for predicting major infections, especially around 5 to 7 days after surgery. Who this helps: This helps doctors monitor patients after stomach surgery to catch potential complications earlier.

Plain English
This study looked at how R1 lymph node dissection status affects survival in patients with stomach cancer who had surgery to try to cure their disease. Researchers analyzed data from 499 patients and found that R1 lymph node dissection is linked to lower disease-specific survival rates, meaning patients with this status had worse outcomes. Specifically, R1 lymph node status was a stronger predictor of local cancer recurrence than the traditionally measured resection margin status. Who this helps: This helps doctors better understand risks for their patients undergoing stomach cancer surgery.

Plain English
This study focused on understanding how to define, diagnose, and treat a specific type of cancer called oligometastatic oesophagogastric cancer, which is when the cancer has spread but is still limited in scope. Experts from 16 European countries reached a consensus on key aspects of this condition, agreeing that it applies to patients with cancer spread to one organ with up to three spots or one lump in a nearby lymph node. The findings will help create standardized criteria for future clinical trials, improving how patients with this type of cancer are treated. Who this helps: This helps patients with oligometastatic oesophagogastric cancer and their doctors.

Plain English
This study looked at gastric cancer patients who received treatment before surgery to see how well their tumors responded. Among 108 patients, only 6.5% had complete tumor regression, but those with higher levels of a protein called HER2 and better nutritional status had a much better chance of achieving this outcome. This is important because patients who responded well to treatment had significantly better survival rates. Who this helps: This helps gastric cancer patients and their doctors understand which factors can lead to better treatment outcomes.

Plain English
This study looked at how often patients develop Clostridium difficile infection (CDI) after having surgery to reverse their temporary stomas, which are often done after treatment for rectal cancer. Out of 126 patients, 6 (or 4.8%) had severe diarrhea and tested positive for CDI, and researchers found that the longer the wait to reverse the stoma, the higher the chance of getting CDI—on average, those with CDI waited 68 weeks for reversal compared to 44.6 weeks for those without symptoms. This matters because understanding the timing of stoma reversal can help reduce the risk of serious infections after surgery. Who this helps: Patients undergoing stoma reversal and their healthcare providers.

Plain English
This study looked at the surgical results of patients with advanced stomach cancer in Europe, focusing on something called "textbook outcome" (TO) and "textbook oncological outcome" (TOO). They found that 68.5% of the 1,700 patients analyzed had a TO, which means they had successful surgeries without serious complications. However, only 22.8% achieved TOO, indicating that many did not receive the recommended chemotherapy treatment alongside surgery. This matters because improving the quality of care and ensuring patients receive the right treatments can lead to better survival rates. Who this helps: This benefits patients with advanced gastric cancer and their healthcare providers.

Plain English
This study looked at how to improve cancer surgery around the world by proposing practical solutions. It found that many regions lack safe and affordable surgical care, and it outlined nine key areas for improvement and identified eight specific actions to enhance surgical access globally. These recommendations are aimed at ensuring that all patients, regardless of where they live or their financial situation, can receive the cancer surgery they need. Who this helps: This benefits cancer patients worldwide.

Plain English
This study looked at how preoperative nutritional screening, a specific recovery protocol (ERAS), and less invasive surgery methods (MIS) impact patients who have gastrointestinal cancer. Researchers analyzed data from 1,648 patients and found that proper nutritional screening and following the ERAS protocol helped reduce hospital stays and complications after surgery, especially for patients with multiple health issues. This matters because it highlights the importance of a team approach in improving patient outcomes after surgery. Who this helps: This benefits patients undergoing surgery for digestive cancers.

Plain English
This study compared two types of surgery for treating cancer in the transverse colon: traditional open surgery and minimally invasive techniques like laparoscopic and robotic surgery. The research involved 388 patients and found that while both methods had similar long-term cancer outcomes and complications, the minimally invasive approach led to faster recovery. For example, patients who had minimally invasive surgery were able to eat solid food sooner and tended to leave the hospital earlier. Who this helps: Patients undergoing surgery for transverse colon cancer.

Plain English
Researchers studied how to predict the risk of cancer returning in the abdomen for patients after surgery for gastric cancer. They created two risk models, called PERI-Gastric 1 and 2, using data from 645 patients and found that the models could accurately assess this risk, achieving scores of 0.828 and 0.805, respectively. This matters because it can help doctors make better treatment decisions and potentially prevent cancer from returning by tailoring follow-up care. Who this helps: This helps patients undergoing surgery for gastric cancer.

Plain English
This study looked at how well surgeons in Europe are trained to perform complex surgeries for advanced pelvic cancers. Out of 280 surgeons who responded to a survey, only 34% were satisfied with their training, and 72% agreed there is a lack of standardized training programs. The findings highlight the need for better training and mentorship in this specialized area, as these improvements could lead to better patient outcomes. Who this helps: This helps patients with advanced pelvic malignancies who need skilled surgical care.

Plain English
This study looked at how multidisciplinary teams in Europe define and treat a specific form of cancer called oligometastatic oesophagogastric cancer, which means that the cancer has spread to a limited number of places in the body. The teams agreed that this cancer type includes patients with 1-2 metastases in certain areas, and they typically recognize the condition after about 18 weeks of therapy if there's no worsening. However, while they had a strong agreement on definitions, there was a lot of variation in treatment methods, with many not reaching a consensus on which approach to take. Who this helps: This information benefits doctors and cancer specialists who are treating patients with oligometastatic oesophagogastric cancer.

Plain English
This article discusses how cancer surgery was affected worldwide during the COVID-19 pandemic, based on feedback from leading cancer surgeons. They found that the pandemic caused major disruptions in care, education, and research, and made existing inequalities in healthcare worse. The experts highlighted the need for new plans to ensure cancer surgeries can continue successfully during future global crises. Who this helps: This helps patients, doctors, and healthcare providers by improving the readiness and quality of cancer care during emergencies.

Plain English
This research focused on defining a specific type of cancer spread, called oligometastatic esophagogastric cancer, and evaluating the effects of local treatment methods (like surgery or targeted radiation) compared to general treatment methods (like chemotherapy). The study found that patients receiving local treatment had better overall survival; those treated locally had a 53% lower risk of dying compared to those who only received systemic therapy (hazard ratio of 0.47). Understanding how to classify this type of cancer and the benefits of local treatments can help improve patient treatment plans and outcomes. Who this helps: This helps patients with oligometastatic esophagogastric cancer.

Plain English
This study looked at how the number of stomach cancer surgeries performed at hospitals in Italy affects patient outcomes, focusing on the rates of death within 30 days of surgery. Researchers found that in 2018, 5,873 stomach cancer surgeries were performed across 498 hospitals, with an average of 11.8 surgeries per hospital. The study revealed that hospitals performing more than 17 surgeries a year had a lower death rate (4.7%) compared to those with only 1 to 3 surgeries (7.7%), showing that higher volumes lead to better outcomes, particularly in regions like southern Italy, where 66.3% of cases may need to be redirected to higher-performing hospitals. Who this helps: This benefits stomach cancer patients by potentially improving their survival rates through better surgical care.

Plain English
This study looked at how safe and effective a specific type of surgery, called totally minimally invasive right colectomy, is for obese patients compared to non-obese patients with right colon cancer. Researchers analyzed data from 184 patients and found that, while the surgery took longer to perform on obese patients, both groups had no major complications during surgery or after, and both groups recovered at similar rates. This means that this surgical approach is safe and works well even for patients with obesity, which is important for treating a growing number of obese individuals with colon cancer. Who this helps: This helps both obese cancer patients and their doctors in making informed treatment decisions.

Plain English
This paper reviews the use of a special imaging technique called near-infrared fluorescence imaging, which uses a dye called indocyanine green, in surgery for stomach cancer. The technique helps surgeons locate important structures during operations, like lymph nodes and blood vessels, and has been well received because it doesn’t increase surgery time or cause side effects. This is important as it can improve the precision of surgeries, leading to better outcomes for patients. Who this helps: This helps patients undergoing gastric cancer surgery and their surgeons.

Plain English
This research looked at the best methods for closing an incision after a minimally invasive stomach surgery in 579 patients with gastric cancer. It found that using a double-layer suture technique with barbed thread resulted in significantly lower rates of bleeding (4.2%) and leakage (2.9%) compared to other methods. This is important because it can lead to better recovery outcomes and fewer complications for patients after surgery. Who this helps: This helps patients undergoing stomach surgery.

Plain English
This study looked at how safe and practical it is for patients to leave the hospital within 72 hours after major colorectal surgery when following a specific recovery program called ERAS. After analyzing data from 788 patients, researchers found no significant differences in complications or readmission rates when comparing those who were discharged early to those who stayed longer, indicating that early discharge is safe. This research is important because it highlights that many patients can recover at home sooner without increasing health risks. Who this helps: This benefits patients undergoing colorectal surgery by allowing them to return home more quickly while maintaining safety.

Plain English
This study looked at how the gut microbiota, the community of bacteria in our intestines, affects the outcomes of colorectal surgery. Researchers found that the gut microbiota plays an important role in complications related to surgery, such as infections and delays in recovery, especially during procedures on the left side of the colon. Using specific treatments, like probiotics or antibiotics before surgery, might help improve recovery and reduce complications. Who this helps: Patients undergoing colorectal surgery.

Plain English
This research focused on improving how doctors manage gastric cancer and tumors at the junction of the stomach and esophagus. The experts identified 49 important questions in areas like diagnosis, treatment for early stages, and how to treat older patients with more advanced disease. Their findings provide clear guidance that can help healthcare providers make better decisions, particularly in complex cases. Who this helps: This benefits doctors treating gastric cancer patients.

Plain English
This study focused on patients who have both colorectal cancer and liver metastases, which are found in 15-25% of them at diagnosis. Researchers in Italy gathered input from 26 medical centers and developed 33 recommendations for minimally invasive surgery that can be performed at the same time for both cancers. These guidelines aim to improve treatment options for patients by offering a more efficient surgical approach, as there's currently no clear standard of care for this scenario. Who this helps: This helps patients with colorectal cancer and liver metastases by providing them with potential treatment options.

Plain English
This paper updates the training guidelines for surgical oncology in Europe, emphasizing the need for consistent education across the continent. It outlines five important areas for future doctors to focus on, such as basic oncology principles and specific skills needed for the European fellowship exam. Uniform training will enhance the quality of care and treatment outcomes for cancer patients. Who this helps: This benefits cancer patients by ensuring that their surgeons are well-trained and knowledgeable.

Plain English
Researchers studied patients with locally advanced rectal cancer who showed significant improvement after initial treatment. They compared the outcomes of those who had surgery to those who chose a conservative approach, like monitoring or local treatments, and found that while both groups had similar survival rates, the conservative approach led to better quality of life, particularly in bowel and sexual functions. It's important because this suggests that some patients may safely avoid major surgery without compromising their health outcomes. Who this helps: This helps patients with rectal cancer who achieve a good initial response to treatment.

Plain English
This study looked at how a special nutrition program called NutriCatt affects older patients undergoing colorectal surgery. Researchers found that patients on the NutriCatt program had better body health markers and experienced fewer serious complications and shorter hospital stays compared to those who followed standard care. Specifically, those using NutriCatt had significant improvements in body composition and a 90% lower risk of severe complications. Who this helps: This benefits elderly patients undergoing colorectal surgery and their healthcare providers.